☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Merck
Merck Reports Results from the P-III (ZENITH) Study of Winrevair (Sotatercept-csrk) for Pulmonary Arterial Hypertension
November 26, 2024
Merck’s Welireg (Belzutifan) Receives Chinese Approval to Treat Certain Types of Von Hippel-Lindau (VHL) Disease-Related Tumors
November 25, 2024
Merck Reports the Data from P-III Study Assessing Subcutaneous Keytruda with Berahyaluronidase Alfa to Treat Metastatic NSCLC
November 20, 2024
Merck Reports the CHMP’s Positive Opinion of Keytruda Plus CT as a 1L Treatment of Unresectable Non-Epithelioid Malignant Pleural...
November 18, 2024
Merck Join Forces with LaNova Medicines to Advance LM-299 for Advanced Solid Tumors
November 15, 2024
Merck Reports EC’s Approval of Keytruda for Two New Indications in Gynecologic Cancers
October 24, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.